Literature DB >> 9142805

Epidemiology and treatment of Cyclospora cayetanensis infection in Peruvian children.

G Madico1, J McDonald, R H Gilman, L Cabrera, C R Sterling.   

Abstract

Cyclospora cayetanensis was detected in fecal specimens from 63 (1.1%) of 5,836 Peruvian children studied over 2 years; the protozoan was detected by modified acid-fast staining and autofluorescence under ultraviolet light. The highest prevalence occurred among children between 2 and 4 years of age. Thirty-two percent (20) of the 63 C. cayetanensis-infected children were symptomatic. Nineteen infected children were enrolled in a double-blind, placebo-controlled trial of a 3-day course of trimethoprim-sulfamethoxazole (TMP-SMZ; 5/25 mg/[kg x d]). Children were followed up with daily stool examinations (mean number of samples examined per child +/- SE, 19 +/- 4). The mean duration of oocyst excretion +/- SE was 4.8 +/- 1.2 days for TMP-SMZ recipients compared with 12.1 +/- 6.1 days for placebo recipients (P < .02). The prevalence of C. cayetanensis infection decreases during winter months and as children age; it decreases precipitously by adulthood. In children in areas of endemicity, C. cayetanensis usually causes mild disease that is often asymptomatic. TMP-SMZ therapy significantly decreases the duration of oocyst excretion.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9142805     DOI: 10.1093/clinids/24.5.977

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  27 in total

1.  Cyclospora in Guatemala: further considerations.

Authors:  Caryn Bern; Michael J Arrowood; Mark Eberhard; James H Maguire
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

2.  Intervening transcribed spacer region 1 variability in Cyclospora cayetanensis.

Authors:  R D Adam; Y R Ortega; R H Gilman; C R Sterling
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

3.  A human disease indicator for the effects of recent global climate change.

Authors:  Jonathan A Patz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

4.  Spatio-temporal surveillance of water based infectious disease (malaria) in Rawalpindi, Pakistan using geostatistical modeling techniques.

Authors:  Sheikh Saeed Ahmad; Neelam Aziz; Amna Butt; Rabia Shabbir; Summra Erum
Journal:  Environ Monit Assess       Date:  2015-08-07       Impact factor: 2.513

5.  Intestinal parasitism in Peruvian children and molecular characterization of Cryptosporidium species.

Authors:  O Cordova Paz Soldan; F Vargas Vásquez; A Gonzalez Varas; G Peréz Cordón; J R Velasco Soto; M Sánchez-Moreno; I Rodríguez Gonzalez; M J Rosales Lombardo
Journal:  Parasitol Res       Date:  2006-01-24       Impact factor: 2.289

6.  Cyclosporiasis: an update.

Authors:  Cirle Alcantara Warren
Journal:  Curr Infect Dis Rep       Date:  2009-03       Impact factor: 3.725

7.  Cyclospora cayetanensis in a pediatric hospital in Morelia, México.

Authors:  Guadalupe E Orozco-Mosqueda; Orlando A Martínez-Loya; Ynes R Ortega
Journal:  Am J Trop Med Hyg       Date:  2014-06-23       Impact factor: 2.345

8.  Epidemiology of Cyclospora cayetanensis and other intestinal parasites in a community in Haiti.

Authors:  Adriana S Lopez; Jean M Bendik; Jean Y Alliance; Jacquelin M Roberts; Alexandre J da Silva; Iaci N S Moura; Michael J Arrowood; Mark L Eberhard; Barbara L Herwaldt
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

9.  Epidemiologic differences between cyclosporiasis and cryptosporidiosis in Peruvian children.

Authors:  Caryn Bern; Ynes Ortega; William Checkley; Jacquelin M Roberts; Andres G Lescano; Lilia Cabrera; Manuela Verastegui; Robert E Black; Charles Sterling; Robert H Gilman
Journal:  Emerg Infect Dis       Date:  2002-06       Impact factor: 6.883

10.  Cyclosporiasis outbreak in Germany associated with the consumption of salad.

Authors:  Peter C Döller; Karl Dietrich; Norbert Filipp; Stefan Brockmann; Caroline Dreweck; Reinhard Vonthein; Christiane Wagner-Wiening; Albrecht Wiedenmann
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.